BIOTRICITY INC.: 10-Q filed 2017-11-14

Name: BIOTRICITY INC.: 10-Q filed 2017-11-14
Creator: BIOTRICITY INC.

What BIOTRICITY INC. reported in its quarterly report filed 2017-11-14 (fiscal Q2 2018): 17 published measures, 44 facts as tagged in accession 0001511164-17-000687.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-14
Fiscal period: fiscal Q2 2018
Accession: 0001511164-17-000687 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOTRICITY INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	667,412	USD
At 2017-03-31	473,512	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	762,804	USD
At 2017-03-31	4,858,328	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	-95,392	USD
At 2017-03-31	-4,384,816	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	607,149	USD
At 2017-03-31	424,868	USD
At 2016-09-30	23,783	USD
At 2016-03-31	53,643	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-1,454,899	USD	92
2017-04-01 to 2017-09-30	-3,758,212	USD	183
2016-07-01 to 2016-09-30	-2,342,448	USD	92
2016-04-01 to 2016-09-30	-3,387,055	USD	183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-04-01 to 2017-09-30	-2,208,129	USD	183
2016-04-01 to 2016-09-30	-1,213,482	USD	183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-04-01 to 2017-09-30	2,340,409	USD	183
2016-04-01 to 2016-09-30	1,403,976	USD	183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-21,581,903	USD
At 2017-03-31	-18,307,215	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-04-01 to 2017-09-30	442,155	USD	183
2016-04-01 to 2016-09-30	196,142	USD	183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	634,412	USD
At 2017-03-31	440,512	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,454,899	USD	92
2017-04-01 to 2017-09-30	2,858,208	USD	183
2016-07-01 to 2016-09-30	1,403,064	USD	92
2016-04-01 to 2016-09-30	2,203,872	USD	183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	413,624	USD	92
2017-04-01 to 2017-09-30	728,734	USD	183
2016-07-01 to 2016-09-30	248,048	USD	92
2016-04-01 to 2016-09-30	514,418	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	21,607,634	shares
At 2017-03-31	18,075,848	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	22,025,886	USD
At 2017-03-31	14,308,583	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-09-30	-583,732	USD
At 2017-03-31	-413,384	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	138,191	USD
At 2017-03-31	271,266	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,041,275	USD	92
2017-04-01 to 2017-09-30	2,129,474	USD	183
2016-07-01 to 2016-09-30	1,155,016	USD	92
2016-04-01 to 2016-09-30	1,689,454	USD	183

Inspect the source

Entity: BIOTRICITY INC. / CIK 0001630113
Captured: 2026-09-21T17:22:14.606Z
SEC response SHA-256: de56e3354d4180362d8bf36a6dd02ff7fd0db9690bc31c81e452959deb9a8d37

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001630113.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))